Cargando…
Therapeutic Management of Adults with Inflammatory Bowel Disease and Malignancies: A Clinical Challenge
SIMPLE SUMMARY: The management and treatment of patients with inflammatory bowel diseases after a diagnosis of malignancy represents a challenge for physicians, since their most common therapy, such as biologics and immunosuppressants, should be discontinued for 2–5 years after the end of cancer tre...
Autores principales: | Ferretti, Francesca, Cannatelli, Rosanna, Maconi, Giovanni, Ardizzone, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856548/ https://www.ncbi.nlm.nih.gov/pubmed/36672491 http://dx.doi.org/10.3390/cancers15020542 |
Ejemplares similares
-
Relevance of sonographic parameters for inflammatory bowel disease in children
por: Dell’Era, Alessandra, et al.
Publicado: (2023) -
Ultrasonographic Evaluation of Intestinal Fibrosis and Inflammation in Crohn’s Disease. The State of the Art
por: Ferretti, Francesca, et al.
Publicado: (2021) -
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022) -
Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021) -
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study
por: Ferretti, Francesca, et al.
Publicado: (2022)